ashby
$231,000–$269,000 / year
Posted 8 weeks ago
Salary: $254,000–$295,000 / year
Position Overview
Bicara Therapeutics is seeking a Senior Director, Quality Management Systems (QMS), reporting to the VP, Global Quality, to build and lead the company’s QMS from the ground up. This hands-on leadership role will establish a scalable, phase-appropriate quality framework that supports all GxP activities while driving speed, operational efficiency, and sustained inspection readiness.
As a key member of the Quality leadership team, this individual will partner closely with GMP and GCP Quality leaders to design and implement pragmatic, risk-based processes and a fit-for-purpose operating model. The role is accountable for establishing robust systems, governance, and tools that support effective execution, while preserving the agility required to scale alongside organizational growth across clinical and commercial activities.
This role is ideal for a leader who excels in a fast-paced, build-mode environment, balancing strategic vision with hands-on execution. The successful candidate brings a collaborative, solutions-oriented approach to partnering across Quality and cross-functional teams and will embed quality into the company’s operating model—fostering accountability, simplicity, and continuous improvement as the organization grows.
This role is based in Boston with a hybrid schedule (three days onsite per week); however, a remote schedule may be considered.
Responsibilities
QMS Leadership
Quality Systems
Inspection Readiness
Operational Effectiveness
Qualifications
Bicara Therapeutics is a clinical-stage biotech company pioneering bifunctional antibodies for targeted tumor modulation. Founded in 2020, we've built a global team of over 100 employees headquartered in Boston, with a clear focus on advancing our lead asset, ficerafusp alfa, or FICERA - a potentially first-in-class bifunctional EGFR-directed antibody combined with a TGF-β ligand trap. Our innovative approach combines tumor-targeting with tumor modulation, where one arm localizes to the tumor while the other serves as a modulator, designed to deliver superior efficacy, improved safety, and enhanced durability directly at the tumor site. FICERA specifically addresses a key challenge in solid tumor treatment by enabling immune cell penetration into tumors, reducing fibrosis and immunosuppression while reversing TGF-β-driven resistance mechanisms - ultimately designed to drive the deep, durable responses that may translate into better outcomes and survival for patients. For more information, please visit www.bicara.com.
Here at Bicara, we believe in building diverse teams and cultivating a culture where all voices are included. We encourage people from all backgrounds to apply.
Bicara Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.